Translational life science research (Lecture 1)
Fundamental life science research is driven by scientific curiosity and does not necessarily have any obvious practical value. By contrast, translational life science research exists in order to solve problems and have a positive social impact rather than to just acquire knowledge for its own sake. This lecture will describe how life science research is translated into new medicines, biomarkers and medical devices.
Bioentrepreneurship (Lecture 2)
One way of translating life science research into a new product is to form a new company. This lecture will describe the process of forming a new company and the complexities of biotechnology commercialization.
Professor Alan M. Palmer FRSB, PhD, MSc, BSc
Professor Palmer was one of the Founders of the first UK neuroscience-based start-up company (Cerebrus Ltd, now Vernalis PLC) and was voted London Biotechnology Network Entrepreneur of the Year in 2005.
He has board level experience in several organisations. Currently, he is a board director of One Nucleus (an international membership organisation for companies working within the life science and healthcare industry), the British Neuroscience Association (the largest UK organisation representing and promoting neuroscience and neuroscientists), Cerestim Ltd (a transcranial brain stimulation company), MS Therapeutics Ltd and The Brain Tumour Charity.
Professor Palmer is a visiting Professor at University College London and the University of Reading and has an honorary position at the University of Bristol. He is also a Fellow of the Royal Society of Biology and an honorary member of the Society for Medicines Research.
He has a BSc in Biochemistry from Warwick University, an MSc from Kings College London (Institute of Psychiatry) and a PhD from University College London (Institute of Neurology).
|Location||Start Date||All Dates||Times||Places Available||Tutor||Book|